Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review.

Kiuchi MG, Esler MD, Fink GD, Osborn JW, Banek CT, Böhm M, Denton KM, DiBona GF, Everett TH 4th, Grassi G, Katholi RE, Knuepfer MM, Kopp UC, Lefer DJ, Lohmeier TE, May CN, Mahfoud F, Paton JFR, Schmieder RE, Pellegrino PR, Sharabi Y, Schlaich MP.

J Am Coll Cardiol. 2019 Jun 18;73(23):3006-3017. doi: 10.1016/j.jacc.2019.04.015. Review.

PMID:
31196459
2.

Aspirin for Primary Prevention of Cardiovascular Diseases: Current Concepts, Unanswered Questions and Future Directions.

Castro-Torres Y, Katholi RE, Yar Khan N.

Hellenic J Cardiol. 2015 Nov-Dec;56(6):461-74. Review. No abstract available.

3.

Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice.

Castro-Torres Y, Carmona-Puerta R, Katholi RE.

World J Clin Cases. 2015 Aug 16;3(8):705-20. doi: 10.12998/wjcc.v3.i8.705. Review.

4.

Natriuretic peptides, obesity and cardiovascular diseases.

Castro-Torres Y, Katholi RE.

Rev Assoc Med Bras (1992). 2015 Jan-Feb;61(1):19-20. doi: 10.1590/1806-9282.61.01.019. Epub 2015 Jan 1. Erratum in: Rev Assoc Med Bras (1992). 2015 May-Jun;61(3):290. Torres, Yaniel Castro [corrected to Castro-Torres, Yaniel].

5.

Renal denervation with vincristine for the treatment of resistant hypertension: further investigations are needed to implement it globally.

Castro Torres Y, Katholi RE.

Hellenic J Cardiol. 2014 Nov-Dec;55(6):514-5. No abstract available.

6.

Novel treatment approaches in hypertensive type 2 diabetic patients.

Castro Torres Y, Katholi RE.

World J Diabetes. 2014 Aug 15;5(4):536-45. doi: 10.4239/wjd.v5.i4.536. Review.

7.

Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel on Renal Sympathetic Denervation.

Angle JF, Prince EA, Matsumoto AH, Lohmeier TE, Roberts AM, Misra S, Razavi MK, Katholi RE, Sarin SN, Sica DA, Shivkumar K, Ahrar K.

J Vasc Interv Radiol. 2014 Apr;25(4):497-509. doi: 10.1016/j.jvir.2013.12.572. Review. No abstract available.

8.

Renal denervation for treating resistant hypertension: current evidence and future insights from a global perspective.

Castro Torres Y, Katholi RE.

Int J Hypertens. 2013;2013:513214. doi: 10.1155/2013/513214. Epub 2013 Nov 27. Review.

9.

Renal sympathetic denervation for treatment-resistant hypertension…in moderation.

Rocha-Singh KJ, Katholi RE.

J Am Coll Cardiol. 2013 Nov 12;62(20):1887-9. doi: 10.1016/j.jacc.2013.06.020. Epub 2013 Jul 10. No abstract available.

10.

Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications.

Katholi RE, Couri DM.

Int J Hypertens. 2011;2011:495349. doi: 10.4061/2011/495349. Epub 2011 Jun 30.

11.

Catheter-based renal sympathetic denervation reduces systolic blood pressure by 32 mm Hg in people with treatment-resistant hypertension.

Katholi RE, Rocha-Singh KJ.

Evid Based Med. 2011 Aug;16(4):109-10. doi: 10.1136/ebm1194. Epub 2011 Mar 3. No abstract available.

PMID:
21377980
12.

Renal nerves in the maintenance of hypertension: a potential therapeutic target.

Katholi RE, Rocha-Singh KJ, Goswami NJ, Sobotka PA.

Curr Hypertens Rep. 2010 Jun;12(3):196-204. doi: 10.1007/s11906-010-0108-4. Review.

PMID:
20424950
13.

The role of renal sympathetic nerves in hypertension: has percutaneous renal denervation refocused attention on their clinical significance?

Katholi RE, Rocha-Singh KJ.

Prog Cardiovasc Dis. 2009 Nov-Dec;52(3):243-8. doi: 10.1016/j.pcad.2009.09.003. Review.

PMID:
19917336
14.

Contrast-induced nephropathy-choice of contrast agents to reduce renal risk.

Katholi RE.

Am Heart Hosp J. 2009 Summer;7(1):45-9. Review.

PMID:
19742433
15.

Contrast-induced nephropathy and long-term adverse events: cause and effect?

Solomon RJ, Mehran R, Natarajan MK, Doucet S, Katholi RE, Staniloae CS, Sharma SK, Labinaz M, Gelormini JL, Barrett BJ.

Clin J Am Soc Nephrol. 2009 Jul;4(7):1162-9. doi: 10.2215/CJN.00550109. Epub 2009 Jun 25.

16.

N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study.

Staniloae CS, Doucet S, Sharma SK, Katholi RE, Mody KR, Coppola JT, Solomon R.

J Interv Cardiol. 2009 Jun;22(3):261-5. doi: 10.1111/j.1540-8183.2009.00456.x. Epub 2009 Mar 13.

PMID:
19490358
17.

Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.

Phillips RA, Fonseca V, Katholi RE, McGill JB, Messerli FH, Bell DS, Raskin P, Wright JT Jr, Iyengar M, Anderson KM, Lukas MA, Bakris GL; GEMINI Investigators.

J Cardiometab Syndr. 2008 Fall;3(4):211-7. doi: 10.1111/j.1559-4572.2008.00017.x.

18.

Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography.

Hardiek KJ, Katholi RE, Robbs RS, Katholi CE.

J Diabetes Complications. 2008 May-Jun;22(3):171-7. doi: 10.1016/j.jdiacomp.2006.11.002. Epub 2008 Apr 16.

PMID:
18413220
19.

Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.

Wright JT Jr, Bakris GL, Bell DS, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Holdbrook FK, Lukas MA, Iyengar M.

J Clin Hypertens (Greenwich). 2007 Nov;9(11):842-9.

20.

Body weight changes with beta-blocker use: results from GEMINI.

Messerli FH, Bell DS, Fonseca V, Katholi RE, McGill JB, Phillips RA, Raskin P, Wright JT Jr, Bangalore S, Holdbrook FK, Lukas MA, Anderson KM, Bakris GL; GEMINI Investigators.

Am J Med. 2007 Jul;120(7):610-5.

PMID:
17602935
21.

Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.

Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, Gelormini JL, Labinaz M, Moreyra AE; Investigators of the CARE Study.

Circulation. 2007 Jun 26;115(25):3189-96. Epub 2007 Jun 11.

PMID:
17562951
22.

Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.

Fonseca V, Bakris GL, Bell DS, McGill JB, Raskin P, Messerli FH, Phillips RA, Katholi RE, Wright JT Jr, Waterhouse B, Lukas MA, Anderson KM; GEMINI Investigators.

Diabet Med. 2007 Jul;24(7):759-63. Epub 2007 Apr 19.

PMID:
17451422
23.

beta-blocker use and diabetes symptom score: results from the GEMINI study.

McGill JB, Bakris GL, Fonseca V, Raskin P, Messerli FH, Phillips RA, Katholi RE, Wright JT Jr, Iyengar M, Anderson KM, Lukas MA, Dalal MR, Bell DS.

Diabetes Obes Metab. 2007 May;9(3):408-17.

PMID:
17391169
24.

Use and side-effect profile of spironolactone in a private cardiologist's practice.

Williams EM, Katholi RE, Karambelas MR.

Clin Cardiol. 2006 Apr;29(4):149-53.

25.

Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.

Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli F, Phillips RA, Raskin P, Wright JT Jr, Waterhouse B, Lukas MA, Anderson KM, Bell DS; GEMINI Investigators.

Hypertension. 2005 Dec;46(6):1309-15. Epub 2005 Nov 14.

PMID:
16286578
26.

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT Jr, Oakes R, Lukas MA, Anderson KM, Bell DS; GEMINI Investigators.

JAMA. 2004 Nov 10;292(18):2227-36.

PMID:
15536109
27.

If LDL-C is the answer...what was the question? What do the data really show?

Katholi RE, Deitrick CL, Hardiek KJ.

Heart Dis. 2001 Jan-Feb;3(1):2-13. Review.

PMID:
11975764
28.

Clinical adaptation of a high-performance liquid chromatographic method for the assay of pyridoxal 5'-phosphate in human plasma.

Deitrick CL, Katholi RE, Huddleston DJ, Hardiek K, Burrus L.

J Chromatogr B Biomed Sci Appl. 2001 Feb 25;751(2):383-7.

PMID:
11236096
29.

Proximal tubule cell response to radiographic contrast media.

Hardiek K, Katholi RE, Ramkumar V, Deitrick C.

Am J Physiol Renal Physiol. 2001 Jan;280(1):F61-70.

30.

Renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography.

Katholi RE, Taylor GJ.

J Am Coll Cardiol. 2000 Jul;36(1):306-7. No abstract available.

31.

Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis.

Rocha-Singh KJ, Mishkel GJ, Katholi RE, Ligon RA, Armbruster JA, McShane KJ, Zeck KJ.

Catheter Cardiovasc Interv. 1999 Jun;47(2):167-72.

PMID:
10376497
32.

Oxygen free radicals and contrast nephropathy.

Katholi RE, Woods WT Jr, Taylor GJ, Deitrick CL, Womack KA, Katholi CR, McCann WP.

Am J Kidney Dis. 1998 Jul;32(1):64-71.

PMID:
9669426
33.

Hypertensive heart disease syndrome in women in a cardiology practice.

Katholi RE, Ervin MR, Ginsburg G.

Compr Ther. 1997 Aug;23(8):508-13.

PMID:
9283740
34.

Nephrotoxicity from contrast media: attenuation with theophylline.

Katholi RE, Taylor GJ, McCann WP, Woods WT Jr, Womack KA, McCoy CD, Katholi CR, Moses HW, Mishkel GJ, Lucore CL, et al.

Radiology. 1995 Apr;195(1):17-22.

PMID:
7892462
35.

A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study).

Taylor GJ, Moses HW, Koester D, Colliver JA, Katholi RE, Dove JT, Woodruff RC, Mikell FL, Becker LC, Sheehan FH, et al.

Am J Cardiol. 1993 Nov 1;72(14):1010-4.

PMID:
8213579
36.

Nephrotoxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double-blind randomized comparison in human beings.

Katholi RE, Taylor GJ, Woods WT, Womack KA, Katholi CR, McCann WP, Moses HW, Dove JT, Mikell FL, Woodruff RC, et al.

Radiology. 1993 Jan;186(1):183-7.

PMID:
8416561
37.

Increased incidence of silent ischemia after acute myocardial infarction.

Taylor GJ, Katholi RE, Womack K, Moses HW, Woods WT.

JAMA. 1992 Sep 16;268(11):1448-50.

PMID:
1512914
38.

Six-year survival after coronary thrombolysis and early revascularization for acute myocardial infarction.

Taylor GJ, Moses HW, Katholi RE, Korsmeyer C, Kolm P, Dove JT, Mikell FL, Sutton JM, Wellons HA, Schneider JA.

Am J Cardiol. 1992 Jul 1;70(1):26-30.

PMID:
1615865
39.

Axial heterogeneity of adenosine transport and metabolism in the rabbit proximal tubule.

Barfuss DW, McCann WP, Katholi RE.

Kidney Int. 1992 May;41(5):1143-9.

40.

Reducing delay in the emergency room in administration of thrombolytic therapy for myocardial infarction associated with ST elevation.

Moses HW, Bartolozzi JJ Jr, Koester DL, Colliver JA, Taylor GJ, Mikell FL, Dove JT, Katholi RE, Woodruff RC, Miller BD, et al.

Am J Cardiol. 1991 Jul 15;68(2):251-3. No abstract available.

PMID:
2063790
41.

Control of artifacts in plasma adenosine determinations.

McCann WP, Katholi RE.

Proc Soc Exp Biol Med. 1990 Sep;194(4):314-9.

PMID:
2117756
42.

Recurrent bacterial endocarditis in a man with tetralogy of Fallot: earliest recurrence on record.

Noreuil TO, Katholi RE, Graham DR.

South Med J. 1990 Apr;83(4):455-7. Review.

PMID:
2108502
43.

Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications.

Taylor GJ, Mikell FL, Moses HW, Dove JT, Katholi RE, Malik SA, Markwell SJ, Korsmeyer C, Schneider JA, Wellons HA.

Am J Cardiol. 1990 Feb 1;65(5):309-13.

PMID:
2105627
44.

The primary care physician and thrombolytic therapy for acute myocardial infarction: comparison of intravenous streptokinase in community hospitals and the tertiary referral center.

Taylor GJ, Song A, Moses HW, Koester DL, Mikell FL, Dove JT, Katholi RE, Wellons HA, Schneider JA.

J Am Board Fam Pract. 1990 Jan-Mar;3(1):1-6.

PMID:
2305636
45.

Endogenous intrarenal adenosine preserves renal blood flow in one-kidney, one clip rats.

Katholi RE, Creek RD, McCann WP.

Hypertension. 1988 Jun;11(6 Pt 2):651-6.

PMID:
3391675
46.

Afferent renal nerves and hypertension.

Katholi RE, Woods WT.

Clin Exp Hypertens A. 1987;9 Suppl 1:211-26.

PMID:
3677453
47.

Renal nerves and hypertension: an update.

Katholi RE.

Fed Proc. 1985 Oct;44(13):2846-50. Review.

PMID:
3899731
48.

Intrarenal adenosine produces hypertension via renal nerves in the one-kidney, one clip rat.

Katholi RE, McCann WP, Woods WT.

Hypertension. 1985 May-Jun;7(3 Pt 2):I88-93.

PMID:
3997236
49.
50.

Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog.

Katholi RE, Whitlow PL, Hageman GR, Woods WT.

J Hypertens. 1984 Aug;2(4):349-59.

PMID:
6397533

Supplemental Content

Loading ...
Support Center